GOVERNMENT-FUNDED
R&D PROJECT
Our Project
Our Project
| Program | Ministry / Agency | Project Title | Total Period | Lead Organization (PI) |
Collaboration |
|---|---|---|---|---|---|
| Tech Start-up Growth & Development Program (Deep-tech TIPS) |
Ministry of SMEs and Startups (MSS) | Development of a high-yield, low-cost BMP-2 production process eliminating refolding based on ChaperNova™ | 2026.04.01 ~ 2029.03.31 | VAXDaIM Inc. (Sungjae Kim) |
— |
| Antiviral Therapeutics Development for RNA Virus Infectious Diseases (Disease X) (R&D) | Korea Health Industry Development Institute (KHIDI) | Development of SARS-CoV-2 infection therapeutics targeting double-membrane vesicles, a key platform for RNA virus replication | 2026.04.01 ~ 2029.12.31 | Catholic University Industry-Academic Cooperation Foundation (Sang-Wook Seo) |
Sungkyunkwan University Industry-Academic Cooperation Foundation, Catholic University Industry-Academic Cooperation Foundation |
| Bio & Medical Commercialization Support Program (Seoul R&D) |
Seoul Business Agency (SBA) | AI-driven discovery of middle molecule drug candidates and process development for NC-LS fusion structure delivery platforms | 2025.09.01 ~ 2027.08.31 | VAXDaIM Inc. (Sungjae Kim) |
Sungshin Women's University Research-Industry Cooperation Foundation (Jaemin Song), 4Bio Korea Co., Ltd. (Changsoo Mok) |
| Public-Private Joint Startup Discovery & Fostering Program (Commercialization) |
Korea Institute of Startup & Entrepreneurship Development (KISED) | Development of avian influenza pandemic preparedness vaccines using an E. coli-based recombinant synthetic antigen vaccine rapid development platform | 2025.10.01 ~ 2027.03.31 | VAXDaIM Inc. (Sungjae Kim) |
— |
| Infectious Disease Prevention & Treatment Technology Development Program (R&D) | Korea Health Industry Development Institute (KHIDI) | Non-clinical research for the development of Japanese encephalitis virus vaccines | 2024.04.01 ~ 2026.06.30 | VAXDaIM Inc. (Sungjae Kim) |
Catholic University Industry-Academic Cooperation Foundation |
| WHO Global Biomanufacturing Workforce Training Hub | Korea Health Industry Development Institute (KHIDI) | WHO Global Biomanufacturing Workforce Training Hub | 2023.12 ~ 2024.06 | International Vaccine Institute (IVI) (Manki Song) |
Korea Health Industry Development Institute (KHIDI), International Vaccine Institute (IVI) |
| Infectious Disease Prevention & Treatment Technology Development Program (R&D) | Korea Health Industry Development Institute (KHIDI) | Non-clinical trial study on T-cell-based universal influenza vaccines | 2023.04.01 ~ 2026.12.31 | VAXDaIM Inc. (Sungjae Kim) |
Ewha Womans University Industry-Collaboration Foundation |
| Rapid Universal Vaccine Technology Development (R&D) | Korea Health Industry Development Institute (KHIDI) | Non-clinical research for vaccine development in response to future West Nile Virus pandemics | 2023.04.01 ~ 2024.12.31 | VAXDaIM Inc. (Sungjae Kim) |
Yonsei University Health System Industry-Academic Cooperation Foundation |

Vaxdigm Co., Ltd.
CEO Sung Jae Kim
TEL 02-6205-2550
EMAIL hydrogold@vaxdigm.com
BUSINESS NUMBER 657-87-02464
ADDRESS 412ho, 201, Songpa-daero, Songpa-gu, Seoul, Republic of Korea
PRIVACY POLICYㅣTERMS AND CONDITIONS
COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.

Vaxdigm Co., Ltd.
CEO Sung Jae Kim
EMAIL hydrogold@vaxdigm.com ㅣ TEL 02-6205-2550
BUSINESS NUMBER 657-87-02464 ㅣ ADDRESS 412ho, 201, Songpa-daero, Sonpa-gu, Seoul, Republic of Korea
PRIVACY POLICYㅣTERMS AND CONDITIONS
COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.